No requirement for src family kinases for PDGF signaling in fibroblasts expressing SV40 large T antigen.

Abstract:

:A growing body of literature suggests that the ubiquitously expressed Src family kinases (Src, Fyn and Yes) are required for agents such as platelet-derived growth factor (PDGF) to stimulate DNA synthesis. Yet Klinghoffer and colleagues recently presented evidence that fibroblasts derived from mice null for Src, Fyn and Yes responded normally to PDGF (Klinghoffer et al., 1999, EMBO J., 18: 2459 - 2471). What is the reason for this discrepancy? We noted that Klinghoffer et al. (1999) used SV40 large T antigen (largeT) to facilitate derivation of cell lines from the embryos. We therefore tested the effect of largeT on PDGF receptor signaling. We found that expression of largeT overcame the inhibitory effects of interfering forms of both Ras (N17Ras) and Src (SrcK-). Furthermore, injection of SrcK- or the cst.1 antibody (which inhibits Src, Fyn and Yes) failed to inhibit PDGF-stimulated DNA synthesis in NIH3T3 cells expressing dominant negative p53, and fibroblasts derived from p53 null embryos. These data suggest firstly that caution should be used in interpretation of experiments conducted in cell lines expressing largeT, and secondly that the role of Src family kinases in growth factor signaling may be to oppose the effects of negative growth regulators such as p53. Oncogene (2000) 19, 2867 - 2869

journal_name

Oncogene

journal_title

Oncogene

authors

Broome MA,Courtneidge SA

doi

10.1038/sj.onc.1203608

subject

Has Abstract

pub_date

2000-06-01 00:00:00

pages

2867-9

issue

24

eissn

0950-9232

issn

1476-5594

journal_volume

19

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype.

    abstract::Castration-resistant prostate cancer (CRPC) continues to pose a significant clinical challenge with new generation second-line hormonal therapies affording limited improvement in disease outcome. As the androgen receptor (AR) remains a critical driver in CRPC, understanding the determinants of its transcriptional acti...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.508

    authors: Robinson JL,Hickey TE,Warren AY,Vowler SL,Carroll T,Lamb AD,Papoutsoglou N,Neal DE,Tilley WD,Carroll JS

    更新日期:2014-12-11 00:00:00

  • Radiation-induced apoptosis is not enhanced by expression of either p53 or BAX in SW626 ovarian cancer cells.

    abstract::The p53 protein is known to play a central role in mediating G1 arrest or apoptosis in response to ionizing radiation in some cell types. It has been proposed that the link between p53 and induction of apoptosis is provided in part by p53-mediated upregulation of BAX. In this study, we used the human SW626 ovarian can...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201132

    authors: Strobel T,Swanson L,Korsmeyer S,Cannistra SA

    更新日期:1997-06-12 00:00:00

  • AMD1 is required for the maintenance of leukemic stem cells and promotes chronic myeloid leukemic growth.

    abstract::Polyamines are critical elements in mammals, but it remains unknown whether adenosyl methionine decarboxylase (AMD1), a rate-limiting enzyme in polyamine synthesis, is required for myeloid leukemia. Here, we found that leukemic stem cells (LSCs) were highly differentiated, and leukemia progression was severely impaire...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-01547-x

    authors: Sari IN,Yang YG,Wijaya YT,Jun N,Lee S,Kim KS,Bajaj J,Oehler VG,Kim SH,Choi SY,Park SH,Kim DW,Reya T,Han J,Kwon HY

    更新日期:2021-01-01 00:00:00

  • HBV integrants of hepatocellular carcinoma cell lines contain an active enhancer.

    abstract::Hepatitis B virus (HBV) infection is a major risk factor worldwide for the development of hepatocellular carcinoma (HCC). Integrated HBV DNA fragments, often highly rearranged, are frequently detected in HCC. In woodchuck, the viral enhancer plays a central role in hepatocarcinogenesis, but in humans the mechanism of ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204879

    authors: Shamay M,Agami R,Shaul Y

    更新日期:2001-10-18 00:00:00

  • TRIM16 acts as a tumour suppressor by inhibitory effects on cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cells.

    abstract::The family of tripartite-motif (TRIM) proteins are involved in diverse cellular processes, but are often characterized by critical protein-protein interactions necessary for their function. TRIM16 is induced in different cancer types, when the cancer cell is forced to proceed down a differentiation pathway. We have id...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.340

    authors: Marshall GM,Bell JL,Koach J,Tan O,Kim P,Malyukova A,Thomas W,Sekyere EO,Liu T,Cunningham AM,Tobias V,Norris MD,Haber M,Kavallaris M,Cheung BB

    更新日期:2010-11-18 00:00:00

  • A kinome-wide shRNA screen uncovers vaccinia-related kinase 3 (VRK3) as an essential gene for diffuse intrinsic pontine glioma survival.

    abstract::Diffuse intrinsic pontine glioma (or DIPG) are pediatric high-grade gliomas associated with a dismal prognosis. They harbor specific substitution in histone H3 at position K27 that induces major epigenetic dysregulations. Most clinical trials failed so far to increase survival, and radiotherapy remains the most effici...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0884-5

    authors: Silva-Evangelista C,Barret E,Ménez V,Merlevede J,Kergrohen T,Saccasyn A,Oberlin E,Puget S,Beccaria K,Grill J,Castel D,Debily MA

    更新日期:2019-09-01 00:00:00

  • Human mammary epithelial cells exhibit a differential p53-mediated response following exposure to ionizing radiation or UV light.

    abstract::The tumor suppressor protein, p53, plays a critical role as a transcriptional activator of downstream target genes involved in the cellular response to DNA damaging agents. We examined the cell cycle checkpoint response of human mammary epithelial cells (HMEC) and their isogenic fibroblast counterparts to ionizing (IR...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202977

    authors: Meyer KM,Hess SM,Tlsty TD,Leadon SA

    更新日期:1999-10-14 00:00:00

  • The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting.

    abstract::NIH sponsored a meeting of medical and veterinary pathologists with mammary gland expertise in Annapolis in March 1999. Rapid development of mouse mammary models has accentuated the need for definitions of the mammary lesions in genetically engineered mice (GEM) and to assess their usefulness as models of human breast...

    journal_title:Oncogene

    pub_type: 共识发展会议,杂志文章,评审

    doi:10.1038/sj.onc.1203277

    authors: Cardiff RD,Anver MR,Gusterson BA,Hennighausen L,Jensen RA,Merino MJ,Rehm S,Russo J,Tavassoli FA,Wakefield LM,Ward JM,Green JE

    更新日期:2000-02-21 00:00:00

  • Target disruption of the mutant beta-catenin gene in colon cancer cell line HCT116: preservation of its malignant phenotype.

    abstract::Most colorectal carcinomas harbor genetic alterations that result in stabilization of beta-catenin. A colorectal carcinoma cell line, HCT116, which has both mutated and wild-type beta-catenin genes, was engineered by homologous recombination to investigate the significance of beta-catenin gene mutation. As expected, t...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205756

    authors: Sekine S,Shibata T,Sakamoto M,Hirohashi S

    更新日期:2002-08-29 00:00:00

  • Bloom's syndrome protein response to ultraviolet-C radiation and hydroxyurea-mediated DNA synthesis inhibition.

    abstract::Bloom's syndrome (BS) arises through mutations in both copies of the BLM gene that encodes a RecQ 3'-5' DNA helicase. BS patients are predisposed to developing all the cancers that affect the general population, and BS cells exhibit marked genetic instability. We showed recently that BLM protein contributes to the cel...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205246

    authors: Ababou M,Dumaire V,Lécluse Y,Amor-Guéret M

    更新日期:2002-03-27 00:00:00

  • Differential effects of the widely expressed dMax splice variant of Max on E-box vs initiator element-mediated regulation by c-Myc.

    abstract::dMax, a naturally occurring splice variant of the Myc binding protein Max, lacks the DNA binding basic region and helix 1 of the Helix-Loop-Helix domain; dMax interacts with c-Myc in vitro and in vivo, and inhibits E-box Myc site driven transcription in transient transfection assays. Here we have investigated the expr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202611

    authors: FitzGerald MJ,Arsura M,Bellas RE,Yang W,Wu M,Chin L,Mann KK,DePinho RA,Sonenshein GE

    更新日期:1999-04-15 00:00:00

  • The actin-associating protein Tm5NM1 blocks mesenchymal motility without transition to amoeboid motility.

    abstract::Cell migration is an integral component of metastatic disease. The ability of cells to transit between mesenchymal and amoeboid modes of migration has complicated the development of successful therapies designed to target cell migration as a means of inhibiting metastasis. Therefore, investigations of the mechanisms t...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.516

    authors: Lees JG,Bach CT,Bradbury P,Paul A,Gunning PW,O'Neill GM

    更新日期:2011-03-10 00:00:00

  • Activation of ATM and Chk2 kinases in relation to the amount of DNA strand breaks.

    abstract::The diverse checkpoint responses to DNA damage may reflect differential sensitivities by molecular components of the damage-signalling network to the type and amount of lesions. Here, we determined the kinetics of activation of the checkpoint kinases ATM and Chk2 (the latter substrate of ATM) in relation to the initia...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207986

    authors: Buscemi G,Perego P,Carenini N,Nakanishi M,Chessa L,Chen J,Khanna K,Delia D

    更新日期:2004-10-07 00:00:00

  • Pim kinase-dependent inhibition of c-Myc degradation.

    abstract::Pim kinases are found to be highly expressed in leukemia, lymphoma, prostate and pancreatic cancer. Bitransgenic mice overexpressing either Pim-1 or Pim-2 and c-Myc succumb to pre-B-cell lymphoma at a strikingly accelerated speed. Despite that Pim-1/Pim-2 has long been recognized as a strong synergistic partner with c...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.123

    authors: Zhang Y,Wang Z,Li X,Magnuson NS

    更新日期:2008-08-14 00:00:00

  • Retrospective analysis of ras gene activation in myeloid leukemic cells.

    abstract::Ras genes are activated by point mutations at critical sites of their coding regions. Activated N-ras genes with transforming ability have been detected in patients with myelodysplastic syndromes (MDS), acute myelogenous leukemia (AML) and in human myeloid cell lines. We used polymerase chain reaction (PCR), different...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Lübbert M,Jonas D,Miller CW,Herrmann F,Mertelsmann R,McCormick F,Koeffler HP

    更新日期:1990-04-01 00:00:00

  • High incidence of medulloblastoma following X-ray-irradiation of newborn Ptc1 heterozygous mice.

    abstract::Individuals affected with the Gorlin syndrome inherit a germ-line mutation of the patched (Ptc1) developmental gene and, analogously to Ptc1 heterozygous mice, show an increased susceptibility to spontaneous tumor development. Human and mouse Ptc1 heterozygotes (Ptc1(+/-)) are also hypersensitive to ionizing radiation...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205973

    authors: Pazzaglia S,Mancuso M,Atkinson MJ,Tanori M,Rebessi S,Majo VD,Covelli V,Hahn H,Saran A

    更新日期:2002-10-24 00:00:00

  • Heregulin is rapidly translocated to the nucleus and its transport is correlated with c-myc induction in breast cancer cells.

    abstract::Heregulins (neuregulins) are a family of proteins known to interact and activate the receptor tyrosine kinases ErbB2 in association with ErbB3 or ErbB4. Using immunofluorescence microscopy, electron microscopy autoradiography, and SDS-PAGE analysis of nuclear fractions, we show that the heregulin-beta1(1-244) isoform ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Li W,Park JW,Nuijens A,Sliwkowski MX,Keller GA

    更新日期:1996-06-06 00:00:00

  • Histone deacetylase 3 localizes to the plasma membrane and is a substrate of Src.

    abstract::Histone deacetylases (HDACs) negatively regulate gene expression by removing acetyl groups from lysine residues present in histones and other proteins. Histone deacetylase 3 is unique among the Class I family of HDACs, as it is able to shuttle between the nucleus and the cytoplasm, whereas the other family members rem...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209473

    authors: Longworth MS,Laimins LA

    更新日期:2006-07-27 00:00:00

  • Cellular immune response to HTLV-1.

    abstract::There is strong evidence at the individual level and the population level that an efficient cytotoxic T lymphocyte (CTL) response to HTLV-1 limits the proviral load and the risk of associated inflammatory diseases such as HAM/TSP. This evidence comes from host population genetics, viral genetics, DNA expression microa...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1208970

    authors: Bangham CR,Osame M

    更新日期:2005-09-05 00:00:00

  • Isolation of HELAD1, a novel human helicase gene up-regulated in colorectal carcinomas.

    abstract::To investigate the mechanisms of colorectal carcinogenesis, we searched for genes regulated by adenomatous polyposis coli gene product (APC) and identified a novel gene, termed HELAD1 (helicase, APC down-regulated 1). A recombinant polypeptide representing the ATPases associated with cellular activities (AAA) domain o...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205751

    authors: Ishiguro H,Shimokawa T,Tsunoda T,Tanaka T,Fujii Y,Nakamura Y,Furukawa Y

    更新日期:2002-09-12 00:00:00

  • The role of BRCA1 in transcriptional regulation and cell cycle control.

    abstract::The exact functions of BRCA1 have not been fully described but it now seems apparent that it has roles in DNA damage repair, transcriptional regulation, cell cycle control and most recently in ubiquitylation. These functions of BRCA1 are most likely interdependent but this review will focus on the role of BRCA1 in rel...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1209872

    authors: Mullan PB,Quinn JE,Harkin DP

    更新日期:2006-09-25 00:00:00

  • Tbx3 impinges on the p53 pathway to suppress apoptosis, facilitate cell transformation and block myogenic differentiation.

    abstract::Tbx3 is a member of the T-box family of transcription factors. Mutations in Tbx3 cause ulnar-mammary syndrome, an autosomal dominant disorder characterized by upper limb defects, apocrine-gland defects including mammary hypoplasia, and tooth, hair and genital defects. In cell culture, Tbx3 and its close relative Tbx2 ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205476

    authors: Carlson H,Ota S,Song Y,Chen Y,Hurlin PJ

    更新日期:2002-05-30 00:00:00

  • Polymorphism of the human c-abl gene: relation to incidence and course of chronic myelogenous leukemia.

    abstract::Abnormalities in structure and expression of the proto-oncogene c-abl have been implicated in the genesis of chronic myelogenous leukemia (CML). We studied leukemic cell DNA from 42 CML patients for evidence of rearrangement and/or amplification of c-abl analogous to that described in the CML cell line K562. Using the...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Daniel L,Ahmed CM,Bloodgood RS,Kidd JR,Castiglione CM,Duttagupta S,Lebowitz P

    更新日期:1987-05-01 00:00:00

  • Interferon γ is a STAT1-dependent direct inducer of BCL6 expression in imatinib-treated chronic myeloid leukemia cells.

    abstract::B-cell CLL/lymphoma 6 (BCL6) exerts oncogenic effects in several human hematopoietic malignancies including chronic myeloid leukemia (CML), where BCL6 expression was shown to be essential for CML stem cell survival and self-renewal during imatinib mesylate (IM) treatment. As several lines of evidence suggest that inte...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.85

    authors: Madapura HS,Nagy N,Ujvari D,Kallas T,Kröhnke MCL,Amu S,Björkholm M,Stenke L,Mandal PK,McMurray JS,Keszei M,Westerberg LS,Cheng H,Xue F,Klein G,Klein E,Salamon D

    更新日期:2017-08-10 00:00:00

  • Regulation of autophagy by ATF4 in response to severe hypoxia.

    abstract::Activating transcription factor 4 (ATF4) is a transcription factor induced under severe hypoxia and a component of the PERK pathway involved in the unfolded protein response (UPR), a process that protects cells from the negative consequences of endoplasmic reticulum (ER) stress. In this study, we have used small inter...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.191

    authors: Rzymski T,Milani M,Pike L,Buffa F,Mellor HR,Winchester L,Pires I,Hammond E,Ragoussis I,Harris AL

    更新日期:2010-08-05 00:00:00

  • CFP suppresses breast cancer cell growth by TES-mediated upregulation of the transcription factor DDIT3.

    abstract::Breast cancer is a heterogeneous genetic disease driven by the accumulation of individual mutations per tumor. Whole-genome sequencing approaches have identified numerous genes with recurrent mutations in primary tumors. Although mutations in well characterized tumor suppressors and oncogenes are overrepresented in th...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0739-0

    authors: Block I,Müller C,Sdogati D,Pedersen H,List M,Jaskot AM,Syse SD,Lund Hansen P,Schmidt S,Christiansen H,Casella C,Bering Olsen S,Blomstrøm MM,Riedel A,Thomassen M,Kruse TA,Karlskov Hansen SW,Kioschis P,Mollenhauer J

    更新日期:2019-06-01 00:00:00

  • Oxamflatin: a novel compound which reverses malignant phenotype to normal one via induction of JunD.

    abstract::In the course of screening for inhibitors of tumorigenic phenotype of K-ras-transformed NIH3T3 cells (DT cells), we found a novel compound, oxamflatin, an aromatic sulfonamide hydroxamate derivative, which induces flat phenotype in these cells and suppresses their anchorage-independent growth. In contrast to DT cells,...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Sonoda H,Nishida K,Yoshioka T,Ohtani M,Sugita K

    更新日期:1996-07-04 00:00:00

  • HPV-16 E7 functions at the G1 to S phase transition in the cell cycle.

    abstract::Previous reports have demonstrated that E7 is the major transforming gene of HPV-16 and that continued expression of the gene is required to maintain the transformed phenotype of primary baby rat kidney cells transformed by HPV-16 E7 and EJ-ras. To investigate the point of action of E7 in the cell cycle we have utilis...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Banks L,Barnett SC,Crook T

    更新日期:1990-06-01 00:00:00

  • Roles of the Pas1 and Par2 genes in determination of the unique, intermediate susceptibility of BALB/cByJ mice to urethane-induction of lung carcinogenesis: differential effects on tumor multiplicity, size and Kras2 mutations.

    abstract::The C3H/HeJ (C3H), A/J and BALB/cByJ (BALB) mouse strains are respectively resistant, sensitive and intermediate regarding the induction of lung tumors by urethane. The phenotypic difference between C3H and A/J is largely determined by the Pas1 (Pulmonary adenoma susceptibility 1) gene on chromosome 6, the A/J allele ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201357

    authors: Karasaki H,Obata M,Ogawa K,Lee GH

    更新日期:1997-10-09 00:00:00

  • Functional analyses and molecular modeling of two c-Kit mutations responsible for imatinib secondary resistance in GIST patients.

    abstract::Imatinib-acquired resistance related to the presence of secondary point mutations has become a frequent event in gastrointestinal stromal tumors. Here, transient transfection experiments with plasmids carrying two different KIT-acquired point mutations were performed along with immunoprecipitation of total protein ext...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209639

    authors: Tamborini E,Pricl S,Negri T,Lagonigro MS,Miselli F,Greco A,Gronchi A,Casali PG,Ferrone M,Fermeglia M,Carbone A,Pierotti MA,Pilotti S

    更新日期:2006-10-05 00:00:00